Latest filing published 12 Aug 2026 for ZEVRA THERAPEUTICS, INC., €53k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +28.6%Entry US$7.32 · Close at T+365 US$9.41
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Corey Michael Watton: trading record in brief
This profile gathers the share dealings of Corey Michael Watton in Zevra Therapeutics, Inc. The record holds 7 filings, for trades running from 30 May 2023 to 10 August 2026.
Market trades split into 5 purchases (€11k) and 1 sale (€120k). On balance, insiders were net sellers of €109k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 option exercise. Since January 2026: no purchases and 1 sale on the market.
Half of the purchases are above €1,903 and half below. Of 5 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 12 August 2026 came the latest disclosure, an option exercise for €53k in Zevra Therapeutics, Inc. The latest purchase dates back some time: it was published 588 days ago, on 31 March 2025. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Corey Michael Watton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,300 shares@ US$4.970.0092% mcap28.8% of flowCommon StockSEC:0001434647-26-000070:0
- 12,300 shares@ US$11.25020.021% mcap65.3% of flowCommon StockSEC:0001434647-26-000070:1
- 300 shares@ US$7.83841.2% of flowCommon StockSEC:0001437749-25-010332:0Canonical exit: 26 Jun 2025 (T+90)
- 500 shares@ US$7.91532.0% of flowCommon StockSEC:0001437749-24-031367:0Canonical exit: 9 Jan 2025 (T+90)
- 275 shares@ US$5.94790.8% of flowCommon StockSEC:0001437749-23-018447:0Canonical exit: 21 Sept 2023 (T+90)
- 325 shares@ US$5.520.9% of flowCommon StockSEC:0001437749-23-017335:0Canonical exit: 7 Sept 2023 (T+90)
- 400 shares@ US$5.10531.0% of flowCommon StockSEC:0001437749-23-016221:0Canonical exit: 28 Aug 2023 (T+90)
7 of 7 declarations